Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.

Purpose: The aim of this study was to describe the efficacy and safety of anti–interleukin 6 receptor antibody (tocilizumab [TCZ]) in patients with severe or refractory Takayasu arteritis (TA). Methods: We describe 8 Colombian patients with severe and/or refractory TA treated with TCZ during a perio...

Full description

Autores:
Cañas Dávila, Carlos Alberto
Tipo de recurso:
Article of investigation
Fecha de publicación:
2014
Institución:
Universidad ICESI
Repositorio:
Repositorio ICESI
Idioma:
eng
OAI Identifier:
oai:repository.icesi.edu.co:10906/78520
Acceso en línea:
http://journals.lww.com/jclinrheum/Abstract/2014/04000/Efficacy_and_Safety_of_Anti_Interleukin_6_Receptor.2.aspx
http://hdl.handle.net/10906/78520
http://dx.doi.org/10.1097/RHU.0000000000000098
Palabra clave:
Arteritis de Takayasu
Tratamiento
Ciencias socio biomédicas
Biomedical sciences
Medicina
Interleukin-6
Reumatología
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/